Top compounds associated with response to FBXO25


Feature Type Standardized
Nominal ANOVA
mRNA PL-DI CTRPv2 pan-cancer AAC 0.16 5e-07
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 6e-07
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.22 7e-07
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 9e-07
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA austocystin d CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 3e-06
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.14 6e-06
Download CSV